Find your favorite nonprofit or choose one that inspires you from our database of over 2 million charitable organizations.
Displaying 73–84 of 3,552
In the fight for a DIPG/DMG cure, we help patients and families by funding game-changing research and providing navigation throughout their journey.
To empower a nation of allies who work with us to provide support for patients and families, caregivers, and survivors; to raise awareness of preventive measures; and inspire efforts to fund critical research. Join our #NationOfAllies and find out how you can make a difference today. Because Tomorrow can’t wait™
Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma-specific charity in the world. With more that 350,000 members in 140 countries, the IMF serves myeloma patients, family members, and the medical community. The IMF provides a wide range of programs in the areas of Research, Education, Support and Advocacy.
METAvivor is dedicated to the specific fight of women and men living with stage 4 metastatic breast cancer. At the time of METAvivor’s founding, no organization was dedicated to funding research for the disease and no patient groups were speaking out about the dearth of stage 4 cancer research. While more and more people have taken up the cry for more stage 4 research, METAvivor remains the sole US organization dedicated to awarding annual stage 4 breast cancer research.
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.
The Lymphoma Research Foundation's mission is to eradicate lymphoma and serve those touched by this disease.
Our mission is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bile duct cancer). Founded in 2006, the Cholangiocarcinoma Foundation (CCF) is a global organization dedicated to curing cholangiocarcinoma (bile duct cancer) and enhancing patients’ quality of life. Through innovative methodologies, partnerships, and support programs, CCF connects patients and caregivers to resources, mentors, and support groups, while also fostering scientific discovery through an annual research fellowship program. CCF has grown to become the leading global resource in research, education, and public awareness.
Founded in 1988 by Paul Newman, The Hole in the Wall Gang Camp is a community dedicated to providing “a different kind of healing” to children and their families coping with cancer, sickle cell anemia, and other serious illnesses. Through summer sessions and family weekends at the Camp in Ashford, Connecticut and year-round outreach to hospitals and clinics across the Northeast, the Camp serves more than 20,000 children and family members annually. All services are provided free of charge.
The Glioblastoma Foundation's mission is to transform the standard of care for Glioblastoma by funding new, more effective treatments, providing support to patients and families touched by the disease, and raising awareness of this rare and aggressive grade 4 brain tumor.
The mission of the American Brain Tumor Association is to advance the understanding and treatment of brain tumors with the goals of improving, extending and, ultimately, saving the lives of those impacted by a brain tumor diagnosis. We do this through interactions and engagements with brain tumor patients and their families, collaborations with allied groups and organizations, and the funding of brain tumor research.
To support medical RESEARCH for finding effective treatments and eventually a cure for melanoma. To EDUCATE patients and physicians about the prevention, diagnosis and treatment of melanoma. To act as an ADVOCATE for the melanoma community to raise awareness of this disease and the need for a cure.
Gilda's Club Madison creates a community of free emotional support, cancer education, and hope for children and adults with any cancer diagnosis and those who care for them.